معرفی
Jinjiang Pang is an Associate Professor in the Department of Medicine at the University of Rochester School of Medicine and Dentistry (SMD). His research focuses on molecular mechanisms of vascular development, angiogenesis, and disease-related vascular dysfunction, particularly in pulmonary hypertension and tumor growth.
- PhD in Cardiovascular Physiology from Peking Union Medical College (2004)
- MS in Muscle Physiology from Lanzhou University (2001)
- Postdoctoral training at University of Rochester (2006-2008) and LSU Health Science Center (2004-2006)
His work integrates angiogenesis, endothelial-mesenchymal transition, and Notch/Wnt signaling to understand vascular network formation and disease pathology. Publications span Cell, Arteriosclerosis, Thrombosis, and Vascular Biology, and Journal of the American Heart Association, with recent focus on mast cell regulation of lung angiogenesis and computational retinal vasculature analysis.
- AHA Innovative Project Award (2019)
- Scientist Development Grant (2008)
- Cournand and Comroe Young Investigator Award (2007)
- Excellent Graduate Awards (2003, 1999)
Current research at the Aab Cardiovascular Research Institute includes vessel pruning, smooth muscle cell dynamics, and therapeutic targeting of angiogenic pathways. Pang's lab also holds a patent for inhibiting angiogenesis via GIT1 inhibitors.
